Hormonal contraception and thrombosis
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (6) , 1289-1294
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Hormonal contraceptives and arterial disease: An epidemiological updateBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolismThe European Journal of Contraception & Reproductive Health Care, 2011
- Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims dataBMJ, 2011
- Epidemiologic Research Using Administrative DatabasesObstetrics & Gynecology, 2010
- Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogestExpert Opinion on Pharmacotherapy, 2010
- Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogestThe European Journal of Contraception & Reproductive Health Care, 2009
- Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutationsBritish Journal of Haematology, 2007
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007
- Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesJournal of Thrombosis and Haemostasis, 2004
- Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trialBlood, 2004